Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-20-051507

Director bought 10,000 shares at $0.72 ($7,245)

From the SEC's structured data for this filing

Trades in this filing

Haddadin Yezan Munther · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-09-22 Purchase : show line 1 in the form +10,000 $0.72 $7,245 10,000 D
Open-market purchases · 10,000 sh · avg $0.72 · $7,245
Loading xslF345X03/doc4.xml…